Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
暂无分享,去创建一个
F. Mandelli | R. Zittoun | B. Rotoli | P. Leoni | V. Liso | T. de Witte | M. Petti | F. Caronia | C. Gattringer | L. Resegotti | T. D. de Witte